Home > National Drug Code (NDC) > Ketorolac Tromethamine

Ketorolac Tromethamine - 10019-029-02 - (Ketorolac Tromethamine)

Alphabetical Index


Drug Information of Ketorolac Tromethamine

Product NDC: 10019-029
Proprietary Name: Ketorolac Tromethamine
Non Proprietary Name: Ketorolac Tromethamine
Active Ingredient(s): 15    mg/mL & nbsp;   Ketorolac Tromethamine
Administration Route(s): INTRAMUSCULAR; INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Ketorolac Tromethamine

Product NDC: 10019-029
Labeler Name: Baxter Healthcare Corporation
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA075772
Marketing Category: ANDA
Start Marketing Date: 20100629

Package Information of Ketorolac Tromethamine

Package NDC: 10019-029-02
Package Description: 25 VIAL in 1 PACKAGE (10019-029-02) > 2 mL in 1 VIAL (10019-029-12)

NDC Information of Ketorolac Tromethamine

NDC Code 10019-029-02
Proprietary Name Ketorolac Tromethamine
Package Description 25 VIAL in 1 PACKAGE (10019-029-02) > 2 mL in 1 VIAL (10019-029-12)
Product NDC 10019-029
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Ketorolac Tromethamine
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAMUSCULAR; INTRAVENOUS
Start Marketing Date 20100629
Marketing Category Name ANDA
Labeler Name Baxter Healthcare Corporation
Substance Name KETOROLAC TROMETHAMINE
Strength Number 15
Strength Unit mg/mL
Pharmaceutical Classes Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]

Complete Information of Ketorolac Tromethamine


General Information